⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 1999Cancer Investigation

Inroads in the Therapy of Indolent Lymphomas: Exploiting Biological Insights

Peter McLaughlin

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

(1999). Inroads in the Therapy of Indolent Lymphomas: Exploiting Biological Insights. Cancer Investigation: Vol. 17, No. 1, pp. 73-86.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Peter McLaughlin (1999) studied this question.

synapsesocial.com/papers/6a168f9166334ab13b050359 https://doi.org/10.1080/07357909909011719

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCohort Study · 1982 · 3,046 citations
2A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Review · 1994 · 6,278 citations
3Bcl-2 initiates a new category of oncogenes: regulators of cell deathOriginal Research · 1992 · 1,121 citations
4Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant LymphomasOriginal Research · 1987 · 675 citations
5Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell lineOriginal Research · 1993 · 878 citations
6Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non- Hodgkin's lymphomaRetrospective Study · 1993 · 59 citations
7Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.Diagnostic Study · 1993 · 72 citations
8All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentClinical Trial · 1991 · 327 citations
9The Coagulation–Immune Axis in Oral Squamous Cell Carcinoma: Mechanisms, Prognostic Significance, and Therapeutic OpportunitiesCancer Investigation · 2026
10SLC9A3R1 Promotes Bladder Cancer Progression Through Regulation of Malignant Phenotypes: Integrated Bioinformatics Analysis and Experimental ValidationCancer Investigation · 2026

More from Cancer Investigation

More from The University of Texas MD Anderson Cancer Center